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Safe Consumption Sites are Critical to Reducing Drug Overdoses
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Fatal drug overdoses surpassed 100,000 in the
United States (U.S.) in 2021, making it the deadliest
year in history. Much of the increase in drug overdose
rates over the past several years has been due to
fentanyl, a highly potent manufactured opioid with
high risk of overdose. Coupled with the risk of
transmission of blood-borne diseases, such as HIV
and Hepatitis C from sharing drug paraphernalia,
individuals who use drugs face numerous challenges
for safely consuming drugs. Because of these
challenges, advocates in the U.S. have been pushing
for the implementation of Safe Consumption Sites
(SCS), which provide safe, medically supervised
spaces for individuals to use drugs. However, there
has been substantial pushback from courts and the
U.S. government, who are concerned that such
establishments would violate 21 U.S. Code 856 maintaining drug-involved premises, also known as
the Crack House Statute.

KEY TAKEAWAYS

•

In 2021, over 100,000 people died from
drug overdoses in the United States,
resulting in the country’s deadliest year on
record for drug overdoses.

•

Safe Consumption Sites (SCS) which
provide safe, medically supervised
spaces for individuals to use drugs, not
only save lives, but they reduce crime,
public nuisance, and drug-related litter.

•

SCS should be implemented across the
country as a harm reduction strategy to
decrease overdose rates and increase
access to supportive services for people
who use drugs.

This brief describes the Crack House Statute, argues for its revocation, and calls for the implementation
of SCS as an important mechanism to decrease overdose rates, increase the uptake of supplemental
support services for people who use drugs, and create safer neighborhoods.

What is the Crack House Statute?

Federal Title 21 U.S. Code 856, “Maintaining drug-involved premises”, makes it unlawful to knowingly
open, lease, rent, use, or maintain any place, whether permanently or temporarily, for the purpose of
manufacturing, distributing, or using any controlled substance.1 Established in the 1980s in response to
the crack epidemic and colloquially referred to as the “Crack House Statute”, the statute lives within the
Anti-Drug Abuse Act of 1986. The focus of the Anti-Drug Abuse Act, passed under the Reagan
Administration, was to shift the response to drug use from a rehabilitative approach to a punitive one.
The largest components of the bill increased spending limits for drug enforcement by $1.7 billion and
set mandatory minimums for certain drug offenses. Only 12% of the funding went toward prevention
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education for youth and no funds were earmarked for harm reduction services such as syringe access.
The Crack House Statute is a direct regulatory policy that uses the government to fully enforce
compliance through a centralized system of law enforcement and specifically targets both dwellers and
owners of properties in the illegal use or distribution of drugs. The Crack House Statute was established
to ensure that drug activity and associated criminal activity do not occur within neighborhoods.
There are several challenges with this policy as it relates to the opioid epidemic, overdose rates, and the
implementation of SCS in the United States. For example, this policy rigidly enforces how private and
public dwellings must operate under the assumption that all drug use and users are criminal and ignores
the science and evidence behind the societal and health benefits of SCS.2 Several cities, including
Philadelphia, New York, San Francisco, and Seattle have recently attempted to implement SCS but
have been met with a swift negative response from the federal government. In January 2021, the 3rd
U.S. Circuit Court of Appeals issued a 2-1 ruling against the development of a SCS by a nonprofit
organization in Philadelphia (Project SafeHouse), enforcing the legal context of the Crack House
Statute.3 Those in favor of the Anti-Drug Abuse Act’s intent applaud the upholding, citing that SCS
enable drug use, cause public nuisance, and increase crime in the neighborhoods where they are
established.
However, some progress has been made. In July 2021, Rhode Island became the first state to legalize the
development of SCS in the U.S. Enacted through state legislation, the policy legalizes SCS and
stipulates that local municipalities must approve their development during a two-year pilot program.4
Unlike previous attempts at establishing SCS, this is the first bill to pass through a state legislature and
the first to not face immediate federal oppositional response. If the policy remains unchallenged by the
federal government, it may be a signal from the Biden Administration that his drug policy agenda would
be opened to amending the Crack House Statute. 5

Safe Consumption Sites Keep People Who Use Drugs Safe

SCS help reduce the risk of overdose and help connect people who use drugs to substance use
treatment and health care services. While variation exists among the services they provide, SCS
typically provide private, sterilized, safe spaces for an individual to consume an illegal drug (typically
through injection). There are mirrors and/or windows in each space that allow for a medical
professional to observe an individual while they use, monitor their behavior, and medically intervene
when necessary. Overall, SCS provide care, comfort, safety, and access to valuable supportive resources
for individuals with problematic substance use.
Safe Consumption Sites Save Lives
Studies from other countries where SCS are allowed show that, among people who use drugs, drug
overdose rates declined at a greater magnitude among those living within the vicinity of a SCS
compared to those who did not. 6,7 A study on an unsanctioned SCS in the U.S. shows that the site was
able to reverse all 33 overdoses that occurred among the 10,514 injections that took place during its
five years of operation (2014-2019).8 The implementation of a safe consumption site in Vancouver,
BC Canada reduced drug overdose mortality by 35% between 2003 and 2005.7
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Safe Consumption Sites Help Reduce Other Harms Associated with Drug Use and
Connect People with Treatment
SCS also reduce other health risks associated with drug use and help people who use drugs to access
substance use treatment and health care services. People who live near SCS are less likely to share drug
paraphernalia, and in turn, less likely to develop injection related skin infections.6 SCS also reduce drug
use trauma (e.g., PTSD, Acute Stress Disorder, violence), and connect people who want to decrease
their drug use to substance use treatment.
Most SCS also provide access or referrals to substance use treatment. A 2021 study6 found that
frequent use of SCS increased the rate of accessing substance use treatment between 1.4 and 1.7 times,
with the likelihood increasing with the number of times an individual accessed the site.
Opponents of SCS are concerned that these facilities enable drug use, but this concern is not warranted.
SCS build trusting connections with people who use drugs9 and in so doing, allow them to feel worthy
of services that may be available to them. These sites do not ignore the realities and risks associated with
drug use, but rather provide safe spaces for individuals to examine their situations and take steps toward
healthier choices while staying live.

Safe Consumption Sites Promote Neighborhood Wellbeing

Residents of communities considering SCS are often concerned about a potential increase in drugrelated litter and criminal activity in their neighborhoods. However, studies in other countries where
SCS are legal show that they improve neighborhood wellbeing and safety, including reductions in
crime, drug-related paraphernalia and other litter, and public nuisances and loitering. 10,11,2
Examination of an unsanctioned U.S. SCS documented a significant decrease in criminal activity (e.g.,
possession, dealing, assault, larceny theft, robbery) in the area surrounding the site. These findings
parallel those from Germany, Australia, and Canada, where SCS are legal, that placement of a SCS
(especially in areas of high drug related crime) reduced the incidence of neighborhood crime.11 It is
likely that providing safe spaces for use of and recovery during drug use minimizes needs (e.g., clothing,
food, shelter, counseling, sterilized drug use equipment), altercations, and public interactions.
In localities where SCS are placed, there is also mutual understanding between the organization running
the site and first responders.10 Police and EMTs are aware of the purposes of the SCS, and while they
will not ignore illegal activity occurring within the vicinity outside of a SCS, there is an understanding
that people who use drugs must feel safe to enter and exit facilities without the fear of legal
repercussions. Therefore, individuals are less likely to “act out” in the vicinity of a SCS for fear that
negative interactions with first responders or the public may lead to the closure of a site.
In concert with decreasing criminal activity, multiple studies have also shown that SCS and other harm
reduction programs have a positive impact on improper syringe disposal. What has been shown for over
20 years through Syringe Exchange Programs, and what continues to be clear with SCS, is that these
sites drastically reduce syringe litter.12 Data from Vancouver, BC showed a 67% reduction in
emergency calls for naloxone treatment and a decrease in drug related hospital admittance by 26%.2
While these statistics highlight positive impacts on the health of people who use drugs, they also
demonstrate a reduction in public nuisance related to these activities. Frequent ambulance calls may be
seen as a public nuisance because they disrupt public activity. People who use drugs are often
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underinsured or lack medical insurance, and therefore, the costs of their medical care often fall to
taxpayers, representing an economic burden to local and state communities. By reducing the number of
ambulance calls to high density drug use locations and the number of hospital admittance, SCS are
decreasing neighborhood disruptions and reducing economic strains within healthcare systems.

We Must Amend the Crack House Statute to Enhance Safe Consumption

While time will tell whether Rhode Island or New York City will be successful in establishing
sanctioned SCS, we must not forget that the Crack House Statute, though important to crime reduction,
was established during the height of the War on Drugs. It is an archaic policy that blocks progress progress that is being made in multiple countries with empirically proven success. If the United States
genuinely wants to reduce drug overdoses, drug-related criminal activity, and negative social
consequences of drug use, the federal government must immediately amend the Crack House Statute to
allow states to establish their own legislation governing SCS.
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